Scientific Frontline: Extended "At a Glance" Summary: Extracellular Contractile Injection Systems for Plant Cell Modification
The Core Concept: A team of Caltech researchers has engineered microscopic bacterial "nanosyringes" to recognize plant cells and inject active, functional proteins directly into them. This mechanism successfully bypasses the formidable barriers of the protective plant cell wall and membrane.
Key Distinction/Mechanism: Traditional genetic modification delivers DNA instructions, requiring the cell to synthesize the desired proteins. In contrast, this approach delivers active proteins directly into the cell, reducing the likelihood of unintended genomic integration. The nanosyringes were modified by replacing their natural target-binding region with a short amino acid chain (flg22), which binds to FLS2 immune receptors on plant cells before a contractile sheath drives an inner tube through the membrane to inject the cargo.
Origin/History: Published on November 18, 2026, in Nature Nanotechnology by researchers led by Gözde Demirer and Mark G. Legendre. The innovation adapts a naturally occurring extracellular contractile injection system originally found in Photorhabdus bacteria, which normally deploys these biological syringes to deliver toxins into insect cells.
Major Frameworks/Components:
- Bacterial Nanosyringes: Phage tail-derived biological nanomachines engineered to translocate protein payloads across cellular membranes.
- Receptor-Mediated Targeting: Utilization of the flg22 peptide to specifically attach to FLS2 (FLAGELLIN SENSITIVE 2) immune receptors natively present on plant surfaces.
- Enzymatic Cargo Delivery: Successful in vivo delivery of Cre recombinase to trigger targeted fluorescence and the genome-engineering protein R2 to insert genetic material at defined genomic loci.
- Model Organisms: Validation in intact leaf tissues of Arabidopsis thaliana and Nicotiana benthamiana.
.jpg)




.jpg)



.png)








.jpg)
.jpeg)